# A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study

> **NCT00675701** · PHASE1 · COMPLETED · sponsor: **CardioKine Inc.** · enrollment: 298 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** placebo
- **DRUG:** lixivaptan
- **DRUG:** moxifloxacin

## Key facts

- **NCT ID:** NCT00675701
- **Lead sponsor:** CardioKine Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2011-06-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675701, "A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00675701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*